CryoLife, Inc. (NYSE: CRY) has received conditional approval of its Investigational Device Exemption (IDE) for PerClot from the United States ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE